EMG
NKTR icon

ETF Managers Group’s Nektar Therapeutics NKTR Stock Holding History

ETF Managers Group’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,200
Closed -$351K – 756
2021
Q1 		$351K Buy
1,200
+161
+15% +$50.1K 0.01% 574
2020
Q4 		$279K Buy
1,039
+93
+10% +$24K 0.01% 556
2020
Q3 		$240K Sell
946
-550
-37% -$173K 0.01% 557
2020
Q2 		$503K Buy
+1,496
New +$467K 0.02% 269
2019
Q3 		– Sell
-1,127
Closed -$586K – 570
2019
Q2 		$586K Sell
1,127
-307
-21% -$154K 0.02% 237
2019
Q1 		$723K Sell
1,434
-126
-8% -$74.7K 0.04% 205
2018
Q4 		$769K Sell
1,560
-222
-12% -$134K 0.04% 203
2018
Q3 		$1.63M Buy
1,782
+456
+34% +$389K 0.06% 141
2018
Q2 		$6.6K Buy
+1,326
New +$1.53M 0.48% 45

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return